Ascend Laboratories LLC recalls Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem
Ascend Laboratories recalls 105mg Minocycline Hydrochloride Extended-Release Tablets due to failed dissolution testing. This may affect medication effectiveness. Contact for return instructions.
Lower-risk recall
Failed Dissolution Specifications: low out of specification results for dissolution testing.
Contact the company & request your remedy
What happened, in plain English
Ascend Laboratories is recalling Minoc: 105mg extended-release tablets that failed dissolution testing. This could mean the medication doesn't work as intended, so affected users should stop using them and contact their doctor. Read more at govinfonow.com/recall/37404-ascend-laboratories-recalls-minocycline-tablets-with-dissolution-testing-failure.
Source Summary by GovInfoNow · govinfonow.com/recall/37404-ascend-laboratories-recalls-minocycline-tablets-with-dissolution-testing-failure · Updated October 5, 2026 · FDA enforcement record: FDA #D-0827-2020
Cite this page
“Ascend Laboratories recalls Minocycline tablets with dissolution testing failure.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37404-ascend-laboratories-recalls-minocycline-tablets-with-dissolution-testing-failure. Based on FDA recall #D-0827-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0827-2020%22&limit=1).
Why it’s dangerous
The tablets failed dissolution testing, meaning they may not release the medication properly in the body. This could lead to reduced effectiveness of the drug. The issue is specific to the manufacturing batch and not a general problem with the product.
Who’s affected
Prescription users of Minocycline Hydrochloride Extended-Release Tablets, 105mg, 30-count bottles manufactured by Alkem Laboratories in India. Patients with specific medical conditions requiring this medication are most at risk.
How to tell if you have this one
Check for the 105mg Minocycline Hydrochloride Extended-Release Tablets, 30-count bottle, manufactured by Alkem Laboratories in Mumbai, India. The product was distributed by Ascend Laboratories in the US and has a specific lot number (19140414) and expiration date (12/2020).
- Brand
Ascend Laboratories- Category
Drug
What to do — step by step
Stop Using It Now
Discard the affected tablets immediately as they may not work properly.
Questions people ask
Is this product safe to use?
The recall is due to failed dissolution testing, which may affect medication effectiveness. Do not use the product until you get further instructions from your doctor.
How do I know if I have the recalled product?
Check for the 105mg Minocycline Hydrochloride Extended-Release Tablets, 30-count bottle, manufactured by Alkem Laboratories in Mumbai, India, with lot number 19140414 and expiration date 12/2020.
What should I do if I have the recalled product?
Discard the product immediately and contact your doctor for further instructions.
Contact Ascend Laboratories
We’ve drafted a message you can send Ascend Laboratories to request your refund or repair — edit it as you like.
Subject: Recall D-0827-2020 — Ascend Laboratories Ascend Laboratories Hello, I own a Ascend Laboratories that is covered by recall D-0827-2020 from Ascend Laboratories. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0827-2020 (January 22, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0827-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.